Abstract:Purpose of review: We describe the epidemiology of the recent global surge in invasive group A streptococcal (GAS) disease and consider its proximate and distal causes. We highlight important knowledge gaps regarding clinical management and discuss potential strategies for prevention. Recent findings: Rates of invasive GAS (iGAS) disease were increasing globally prior to the COVID-19 pandemic. Since mid-2022, following the worst years of the pandemic in 2020 and 2021, many countries with systems to monitor GAS syndromes have reported surges in cases of iGAS concurrent with increased scarlet fever, pharyngitis, and viral co-infections. The emergence of the hypervirulent M1 UK strain as a cause of iGAS, particularly in high income countries, is concerning. New data are emerging on the transmission dynamics of GAS. GAS remains universally susceptible to penicillin but there are increasing reports of macrolide and lincosamide resistance, particularly in invasive isolates, with uncertain clinical consequences. Intravenous immunoglobulin is used widely for streptococcal toxic shock syndrome and necrotizing soft tissue infections, although there is limited clinical evidence, and none from a completed randomized controlled trial. Intensive and expensive efforts at population-level control of GAS infections and postinfectious autoimmune complications have been only partially successful. The great hope for control of GAS diseases remains vaccine development. However, all modern vaccine candidates remain in the early development stage. Summary: In many countries, iGAS rates surged from mid-2022 in the aftermath of pandemic control measures and physical distancing. The emergence of a dominant hypervirulent strain is an important but incomplete explanation for this phenomenon. Clinical management of iGAS remains highly empirical and new data has not emerged. A vaccine remains the most likely means of achieving a sustainable reduction in the burden of iGAS.

Postpartum Invasive Group A Streptococcus Infection: Case Report and Mini-review

Surviving Postpartum Group A Streptococcus Sepsis Complicated by Multiorgan System Failure: A Complex Case Presentation

[Group A-streptococcal infection during pregnancy]

Successful Treatment of Group A Streptococcal Toxic Shock Syndrome Occurring in Late Pregnancy: a Case Report.

Perinatal group A streptococcal infection in vagina and its impact on pregnancy outcomes

The Thousand Faces of Invasive Group A Streptococcal Infections: Update on Epidemiology, Symptoms, and Therapy

Outbreak of postpartum group a Streptococcus infections on a labor and delivery unit

Group A streptococcal sepsis and ovarian vein thrombosis after an uncomplicated vaginal delivery

Invasive group A streptococcal infection can be fatal to pregnant women in restricted medical resources remote areas—Emergent alert after COVID‐19 pandemic

Chains of misery: surging invasive group A streptococcal disease

Pyoderma Gangrenosum, a Challenging Postpartum Diagnosis—Case Report and Literature Review

Group B Streptococcus infection-induced ovarian vein thrombosis identified during cesarean section: A case report and a literature review

Invasive Group A Streptococcal Infections in Pediatric Critical Care: A Retrospective Cohort Study

Severe group A streptococcal infections in a paediatric intensive care unit

Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series

Group B streptococcal chorioamnionitis and neonatal septicemia following 8 days pivampicillin and metronidazol prophylaxis after premature rupture of membranes; a case report

The current status of Group B Streptococcus infection in the reproductive tract of late-pregnancy women and its impact on pregnancy outcomes

Group B Streptococcus and Intraamniotic Inflammation and Infection

Out with the Old, In with the New: A Review of the Treatment of Intrapartum Infections

Analysis of invasive group A streptococcal puerperal sepsis in Calgary, Alberta: clinical consequences and policy implications

Maternal septicemia caused by Streptococcus mitis: a possible link between intra-amniotic infection and periodontitis. Case report and literature review